Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

KERLEDEX

BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE

Standard Dose
5MG;12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview KERLEDEX is listed in Drugs@FDA under application 019807 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE Form and strength TABLET;ORAL - 5MG;12.5MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview KERLEDEX is listed in Drugs@FDA under application 019807 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE Form and strength TABLET;ORAL - 5MG;12.5MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.